Gregory Berk serves as Executive at Hana Biosciences Inc, where they oversee executive responsibilities. Since joining the company, Gregory Berk has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 16, 2021 involved receiving (via award) 278,058 shares valued at $0.
Gregory Berk currently holds 278,058 shares of Hana Biosciences Inc (HNAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Berk has been a net neutral trader of HNAB stock. They have purchased $0 and sold $0 worth of shares.
Gregory Berk's most recent insider trade was on Feb 16, 2021, when they sold 278,058 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |